Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma
Clinical trial NCT00742027 · COMPLETED
Trial details
- NCT number
- NCT00742027
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-16
- Primary completion
- 2013-08-12
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.